| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |